Decreased expression of the melatonin receptor 1 in human colorectal adenocarcinomas

Journal of Biological Regulators and Homeostatic Agents

Volumn 25, Issue 4, 2011, Pages 531-542

  Nemeth, C ^a   Humpeler, S ^a,b   Kallay, E ^a   Mesteri, I ^a   Svoboda, M ^a   Rogelsperger O ^a   Klammer, N ^a,b   Thalhammer, T ^a   Ekmekcioglu, Cem ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Cluster for Rheumatology Balneology and Rehabilitation   (Austria)

Author keywords

Clock genes; Human colorectal cancer; Melatonin receptor

Indexed keywords

CRYPTOCHROME 1; MELATONIN 1 RECEPTOR; MESSENGER RNA;

ARTICLE; CANCER GRADING; COLON; COLORECTAL CARCINOMA; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CLOCK PROTEINS; COLONIC NEOPLASMS; CRYPTOCHROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTOR, MELATONIN, MT1; RNA, MESSENGER;

EID: 84855997014     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Reiter RJ, Tan DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 181:127-51.
2. Cardinali DP, Pevet P. Basic aspects of melatonin action. Sleep Med Rev 1998; 2:175-90. (Pubitemid 128646531)
3. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42:28-42. (Pubitemid 44924323)
4. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006; 60:97-108.
5. Weaver DR, Reppert SM. The Mella melatonin receptor gene is expressed in human suprachiasmatic nuclei. Neuroreport 1996; 8:109-12. (Pubitemid 126785541)
6. Ekmekcioglu C, Thalhammer T, Humpeler S, et al. The melatonin receptor subtype MT2 is present in the human cardiovascular system. J Pineal Res 2003; 35:40-44. (Pubitemid 36819169)
7. Poon AM, Mak AS, Luk HT. Melatonin and 2[125I]iodomelatonin binding sites in the human colon. Endocr Res 1996; 22:77-94.
8. Hansen J. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control 2006; 17:531-37.
9. Blask DE, Brainard GC, Dauchy RT, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005; 65:11174-84. (Pubitemid 41713389)
10. Hill SM, Frasch T, Xiang S, et al. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 2009; 8:337-46.
11. Dillon DC, Easley SE, Asch BB, et al. Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 2002; 118:451-58. (Pubitemid 37046344)
12. Lai L, Yuan L, Cheng Q, et al. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat 2009; 118:293-305.
13. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47:2336-48. (Pubitemid 35205309)
14. Garcia-Navarro A, Gonzalez-Puga C, Escames G, et al. Cellular mechanisms involved in the melatonin inhibition of HT-29 human colon cancer cell proliferation in culture. J Pineal Res 2007; 43:195-205. (Pubitemid 47078925)
15. Winczyk K, Fuss-Chmielewska J, Lawnicka H, Pawlikowski M, Karasek M. Luzindole but not 4-phenyl-2- propionamidotetralin (4P-PDOT) diminishes the inhibitory effect of melatonin on murine Colon 38 cancer growth in vitro. Neuro Endocrinol Lett 2009; 30:657-62.
16. Pardini L, Kaeffer B, Trubuil A, Bourreille A, Galmiche JP. Human intestinal circadian clock: expression of clock genes in colonocytes lining the crypt. Chronobiol Int 2005; 22:951-61. (Pubitemid 43062243)
17. Krugluger W, Brandstaetter A, Kallay E, et al. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 2007; 67:7917-22. (Pubitemid 47281388)
18. Mazzoccoli G. The timing clockwork of life. J Biol Regul Homeost Agents 2011; 25:137-43.
19. Gery S, Komatsu N, Baldjyan L, et al. The circadian gene perl plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006; 22:375-82.
20. Chen ST, Choo KB, Hou MF, et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005; 26:1241-46.
21. Imbesi M, Arslan AD, Yildiz S, et al. The melatonin receptor MTl is required for the differential regulatory actions of melatonin on neuronal 'clock' gene expression in striatal neurons in vitro. J Pineal Res 2009; 46:87-94.
22. Stebelova K, Anttila K, Manttari S, Saarela S, Zeman M. Immunohistochemical definition of MT(2) receptors and melatonin in the gastrointestinal tissues of rat. Acta Histochem 2011; 112:26-33.
23. Sotak M, Mrnka L, Pacha J. Heterogeneous expression of melatonin receptor MT1 mRNA in the rat intestine under control and fasting conditions. J Pineal Res 2006; 41:183-88. (Pubitemid 44141754)
24. Lee PP, Pang SF. Melatonin and its receptors in the gastrointestinal tract. Biol Signals 1993; 2:181-93. (Pubitemid 24084998)
25. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003; 95:825-28. (Pubitemid 36798430)
26. Kos-Kudla B, Ostrowska Z, Kozlowski A, et al. Circadian rhythm of melatonin in patients with colorectal carcinoma. Neuro Endocrinol Lett 2002; 23:239-42. (Pubitemid 34741933)
27. Pandi-Perumal SR, Trakht I, Srinivasan V, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008; 85:335-53.
28. Cerea G, Vaghi M, Ardizzoia A, et al. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res 2003; 23:1951-54. (Pubitemid 36750873)
29. Tanaka T, Yasui Y, Tanaka M, et al. Melatonin suppresses AOM/DSS-induced large bowel oncogenesis in rats. Chem Biol Interact 2009; 177:128-36.
30. Aust S, Thalhammer T, Humpeler S, et al. The melatonin receptor subtype MT1 is expressed in human gallbladder epithelia. J Pineal Res 2004; 36:43-48. (Pubitemid 38130288)
31. Borgs L, Beukelaers P, Vandenbosch R, et al. Cell "circadian" cycle: new role for mammalian core clock genes. Cell Cycle 2009; 8:832-37.
32. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111:41-50.
33. Dardente H, Menet JS, Poirel VJ, et al. Melatonin induces Cry1 expression in the pars tuberalis of the rat. Brain Res Mol Brain Res 2003; 114:101-106. (Pubitemid 36773550)
34. Fustin JM, O'Neill JS, Hastings MH, Hazlerigg DG, Dardente H. Cryl circadian phase in vitro: wrapped up with an E-box. J Biol Rhythms 2009; 24:16-24.